期刊文献+

影响血栓性血小板减少性紫癜治疗的预后因素分析 被引量:2

Analysis of influence factor on the prognosis of thrombotic thrombocytopenic purpura
下载PDF
导出
摘要 目的:通过回顾性分析12年中在我院住院治疗的19例血栓性血小板减少性紫癜( TTP)患者的临床特点,评估其临床表现、治疗和预后的相关性。方法统计19例TTP患者的临床表现,治疗方案和治疗期间的血红蛋白( HGB)、血小板( PLT)、乳酸脱氢酶( LDH)和间接胆红素( IBIL),了解其对预后的影响。结果19例患者均存在不同程度的PLT降低和神经精神症状,随着病程的进展,HGB逐渐下降,而发热和肾功能损害的表现程度不一。根据患者的转归将其分为好转组和死亡组,统计发现死亡组在治疗期间LDH和IBIL明显高于好转组。15例患者在治疗过程中接受血浆置换治疗,治愈率为80%,而是否使用大剂量激素冲击治疗对患者的转归没有影响。结论①程度不一的PLT减少和神经精神症状是TTP中最常见的临床表现;②外周血破碎红细胞的监测能为早期诊断提供证据;③在治疗过程中,LDH和IBIL水平的变化对转归的判断具有指导意义;④血浆置换是治疗TTP的有效手段,但大剂量激素治疗对预后并无影响。 Objective To retrospectively analyze 19 cases with thrombotic thrombocytopenic purpura ( TTP) during the past 12 years, and evaluate the relationship between the clinical features , therapy methods and prognosis . Methods In order to understand the influencing factors on the prognosis of the TTP patients , clinical data of 19 patients were analyzed , including the clinical features , therapy methods, hemoglobin, platelet, lactate dehydrogenase (LDH) and indirect bilirubin (IBIL). Results There were different degree of platelet reducing and neurological manifestations .As the disease developing , the hemoglobin decreased .The degrees of fever and renal injure were inconformity .The patients were divided into two groups according the prognosis; the LDH and IBIL of dead group were higher than favourable group in the course of therapy .Fifteen cases received plasma exchange , and survival ratio was 80%.And the glucocorticoid impact treatment had no influence on the prognosis . Conclusion ①The most common features of TTP are platelet reducing and neurological manifestations ,②fractured red blood cells can provide the clue for diagnosis , ③in the therapy course , the changes of LDH and IBIL can indicate prognosis ,④plasma exchange is a effective treatment for TTP , and the high dose glucocorticoid therapy has no influence on prognosis .
出处 《中国急救医学》 CAS CSCD 北大核心 2014年第9期810-813,共4页 Chinese Journal of Critical Care Medicine
基金 全国临床重点专科建设项目
关键词 血栓性血小板减少性紫癜(TTP) 临床分析 预后 Thrombotic thrombocytopenic purpura Clinical analysis Prognosis
  • 相关文献

参考文献7

  • 1Blombery P, Marie S. Management of thrombotic thrombocytope- nic purpura: current perspectives [ J ]. J Blood Med,2014, 5 ( 1 ) : 15 -23.
  • 2Amorosi E, Ultmann J. Thrombotic thrombocytopenie purpura: re- port of 16 cases and review of the literature[ J]. Medicine, 1966, 45(2) : 139 -159.
  • 3Rock GA, Shumak KH, Buskard NA, et al. Comparison of plas- ma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group [ J ]. N Engl J Med,1991, 325(6) : 393 -397.
  • 4Balduini CL, Gugliotta L, Luppi M, et al. High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpra: a randomized study[ J]. Ann Hematol, 2010, 89(6) : 591 -596.
  • 5Cohen JA, Brecher ME, Bandarenko N. Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic throm- bocytopenic purpura [ J ]. J Clin Pheresis, 1998, 13 ( 1 ) : 16 - 19.
  • 6Kilercik M, Coskun A, Serteser M, et al. Biological variations of ADAMTS13 and yon Willebrand factor in human adults[ J]. Bio- chem Med, 2014, 24(1 ): 138- 145.
  • 7Sadler JE. Von Willebrand factor, ADAMTSI3, and thrombotic thrombocytopenic purpura[ J]. Blood, 2008, 112( 1 ) : 11 - 18.

同被引文献22

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部